debutylbupivacaine
CAS No. 15883-20-2
debutylbupivacaine( Desbutylbupivacaine | Debutylbupivacaine | Demethylmepivacaine )
Catalog No. M12267 CAS No. 15883-20-2
It is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 43 | In Stock |
|
| 100MG | 63 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 155 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namedebutylbupivacaine
-
NoteResearch use only, not for human use.
-
Brief DescriptionIt is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
-
DescriptionIt is the intermediate of Ropivacaine Hydrochloride and Bupivacain.
-
In Vitro——
-
In Vivo——
-
SynonymsDesbutylbupivacaine | Debutylbupivacaine | Demethylmepivacaine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15883-20-2
-
Formula Weight232.32
-
Molecular FormulaC14H20N2O
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESO=C(C1NCCCC1)NC2=C(C)C=CC=C2C
-
Chemical Name2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Grossamide
Grossamide possesses potential anti-inflammatory effects, it also has potential anti-neuroinflammatory effects against lipopolysaccharide (LPS)-induced inflammatory response in BV2 microglia cells. Cis-Grossamide K exerts a particularly strong anti-melanogenic activity on the cells without high cell toxicity.
-
RS 17053 hydrochlori...
RS 17053 hydrochloride is an effective and selective antagonist of α1A-adrenergic receptor with pA2 of 9.8 in functional assays and pKi of 9.1 in the native cell membrane.
-
IMT1B
IMT1B is an orally active, noncompetitive and specific allosteric inhibitor of mitochondrial RNA polymerase (POLRMT) and inhibits mitochondrial DNA (mtDNA) expression. It has anti-tumour effects.
Cart
sales@molnova.com